Application of a Mindfulness and Self-Compassion Program in Patients With Schizophrenia. Randomized Controlled Trial.
- Conditions
- Schizophrenia
- Registration Number
- NCT04144075
- Lead Sponsor
- Gutiérrez-Hernández, ME
- Brief Summary
This is a randomized clinical trial to check whether the quality of life of patients with schizophrenia improves after participation in the mindfulness and self-compassion (MSC) programme.
- Detailed Description
MAIN AIM To check whether the quality of life of patients with schizophrenia improves after participation in the mindfulness and self-compassion (MSC) programme, compared with those participating in an active control programme or those following usual treatment.
DESIGN
Randomized clinical trial, three parallel groups:
1. Experimental, which will receive the MSC together with the usual treatment (TAU).
2. Active control, which will receive an alternative programme with cognitive, behavioural and psychoeducational components (CBTG) together with the TAU.
3. Passive control, which will receive the TAU. STUDY DISORDER
Schizophrenia. DATA FROM THE INTERVENTION UNDER STUDY Program developed by Kristin Neff and Christopher Germer, after observing in diverse investigations the inverse correlation between levels of self-pity and diverse pathological clinical variables.
POPULATION UNDER STUDY Patients from Telde's Mental Health Unit who have been diagnosed with schizophrenia.
TOTAL NUMBER OF SUBJECTS 150
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 150
- Diagnosis of schizohrenia
- Drug addict
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method World Health Organization Quality of Life Instument. WHOQOL-BREF 15 minutes Scores from 5 to 130, the higher score the worse outcome.
- Secondary Outcome Measures
Name Time Method Self-compassion scale (SCS) 15 minutes Scores from 5 to 130, the higher score the worse outcome